Literature DB >> 19643159

Molecular evidence for an involvement of organic anion transporters (OATs) in aristolochic acid nephropathy.

Nadiya Bakhiya1, Volker M Arlt, Andrew Bahn, Gerhard Burckhardt, David H Phillips, Hansruedi Glatt.   

Abstract

Aristolochic acid (AA), present in Aristolochia species, is the major causative agent in the development of severe renal failure and urothelial cancers in patients with AA nephropathy. It may also be a cause of Balkan endemic nephropathy. Epithelial cells of the proximal tubule are the primary cellular target of AA. To study whether organic anion transporters (OATs) expressed in proximal tubule cells are involved in uptake of AA, we used human epithelial kidney (HEK293) cells stably expressing human (h) OAT1, OAT3 or OAT4. AA potently inhibited the uptake of characteristic substrates, p-aminohippurate for hOAT1 and estrone sulfate for hOAT3 and hOAT4. Aristolochic acid I (AAI), the more cytotoxic and genotoxic AA congener, exhibited high affinity for hOAT1 (K(i)=0.6 microM) as well as hOAT3 (K(i)=0.5 microM), and lower affinity for hOAT4 (K(i)=20.6 microM). Subsequently, AAI-DNA adduct formation (investigated by (32)P-postlabelling) was used as a measure of AAI uptake. Significantly higher levels of adducts occurred in hOAT-expressing cells than in control cells: this effect was abolished in the presence of the OAT inhibitor probenecid. In Xenopus laevis oocytes hOAT-mediated efflux of p-aminohippurate was trans-stimulated by extracellular AA, providing further molecular evidence for AA translocation by hOATs. Our study indicates that OATs can mediate the uptake of AA into proximal tubule cells and thereby participate in kidney cell damage by this toxin. 2009 Elsevier Ireland Ltd.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19643159     DOI: 10.1016/j.tox.2009.07.014

Source DB:  PubMed          Journal:  Toxicology        ISSN: 0300-483X            Impact factor:   4.221


  22 in total

Review 1.  The SLC22 Transporter Family: A Paradigm for the Impact of Drug Transporters on Metabolic Pathways, Signaling, and Disease.

Authors:  Sanjay K Nigam
Journal:  Annu Rev Pharmacol Toxicol       Date:  2018-01-06       Impact factor: 13.820

Review 2.  Renal organic anion transporters (SLC22 family): expression, regulation, roles in toxicity, and impact on injury and disease.

Authors:  Li Wang; Douglas H Sweet
Journal:  AAPS J       Date:  2012-10-09       Impact factor: 4.009

3.  Human liver-kidney model elucidates the mechanisms of aristolochic acid nephrotoxicity.

Authors:  Shih-Yu Chang; Elijah J Weber; Viktoriya S Sidorenko; Alenka Chapron; Catherine K Yeung; Chunying Gao; Qingcheng Mao; Danny Shen; Joanne Wang; Thomas A Rosenquist; Kathleen G Dickman; Thomas Neumann; Arthur P Grollman; Edward J Kelly; Jonathan Himmelfarb; David L Eaton
Journal:  JCI Insight       Date:  2017-11-16

4.  Renal liver-type fatty acid binding protein (L-FABP) attenuates acute kidney injury in aristolochic acid nephrotoxicity.

Authors:  Katsuomi Matsui; Atsuko Kamijo-Ikemorif; Takeshi Sugaya; Takashi Yasuda; Kenjiro Kimura
Journal:  Am J Pathol       Date:  2011-03       Impact factor: 4.307

5.  Physiological and molecular characterization of aristolochic acid transport by the kidney.

Authors:  Kathleen G Dickman; Douglas H Sweet; Radha Bonala; Tapan Ray; Amy Wu
Journal:  J Pharmacol Exp Ther       Date:  2011-05-05       Impact factor: 4.030

Review 6.  What do drug transporters really do?

Authors:  Sanjay K Nigam
Journal:  Nat Rev Drug Discov       Date:  2014-12-05       Impact factor: 84.694

7.  Handling of Drugs, Metabolites, and Uremic Toxins by Kidney Proximal Tubule Drug Transporters.

Authors:  Sanjay K Nigam; Wei Wu; Kevin T Bush; Melanie P Hoenig; Roland C Blantz; Vibha Bhatnagar
Journal:  Clin J Am Soc Nephrol       Date:  2015-10-21       Impact factor: 8.237

8.  The molecular mechanism of leptin secretion and expression induced by aristolochic acid in kidney fibroblast.

Authors:  Tsung-Chieh Lin; Tien-Chiang Lee; Shih-Lan Hsu; Chung-Shi Yang
Journal:  PLoS One       Date:  2011-02-03       Impact factor: 3.240

Review 9.  Assessment of the role of renal organic anion transporters in drug-induced nephrotoxicity.

Authors:  Yohannes Hagos; Natascha A Wolff
Journal:  Toxins (Basel)       Date:  2010-08-09       Impact factor: 4.546

10.  Interaction of Natural Dietary and Herbal Anionic Compounds and Flavonoids with Human Organic Anion Transporters 1 (SLC22A6), 3 (SLC22A8), and 4 (SLC22A11).

Authors:  Li Wang; Douglas H Sweet
Journal:  Evid Based Complement Alternat Med       Date:  2013-03-21       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.